Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
35Pharma is a biopharmaceutical company that designs and develops innovative biologics for diseases of high unmet medical need.
Vima Therapeutics operates as a biotechnology company.
AirNexis Therapeutics develops clinical-stage therapies for chronic obstructive pulmonary disease and other pulmonary conditions.
Diagonal Therapeutics is a biotechnology startup that develops targeted therapies for cancer and genetic diseases.
Braveheart Bio is a clinical-stage biotechnology company focused on developing precision therapies in the cardiovascular disease space.
Maze Therapeutics is a biotechnology company that develops precision medicines for renal, cardiovascular, and metabolic diseases.
Enlaza Therapeutics is a biotechnology research company.
Trevi Therapeutics is a clinical-stage biopharmaceutical company that develops drugs for treating uremic pruritus.
ORIC Pharmaceuticals is a biopharmaceutical company that develops treatments that target the causes of therapeutic resistance.
Attovia Therapeutics is a biologics platform specializing in biotherapeutics for immune-mediated diseases.
Hillstar Bio is developing precision immunotherapies to treat autoimmune diseases.
Alesta Therapeutics focused on translating novel targets in the chronic stress response pathways into new therapeutic.
GondolaBio researches, develops and manufactures pharmaceutical products.
Halda Therapeutics is a research-stage drug discovery company.
Scorpion Therapeutics is a clinical-stage oncology company that specializes in precision medicine for cancer patients.
Bluejay Therapeutics is a private biopharmaceutical company focused on the development of cures for infectious diseases.
Applied Therapeutics uses drug-development approach to target molecules and pathways that has roles in fatal or debilitating diseases.
Sudo Biosciences is a biopharma company that designs and develops medicines that target the tyrosine kinase 2 (TYK2) pseudokinase domain.
Lassen Therapeutics develops antibody biotherapeutics to help improve the lives of patients suffering from serious diseases.
Radionetics Oncology is a pharmaceutical company that focuses on the discovery and development of novel radiotherapeutics.
Krystal Biotech provide significant clinical benefit for patients suffering from rare debilitating disorders..
Frazier Life Sciences has invested in 46 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
Frazier Life Sciences's top investment sectors include Biotechnology, Health Care, Therapeutics, Medical, Biopharma. The firm invests across 12 different industry categories.
Among tracked funding rounds, GondolaBio received $300.0M in a Series Unknown round. Frazier Life Sciences's total known invested capital is $5.3B.
Frazier Life Sciences's average investment size is $117.7M across its portfolio of 46 companies.
Recent Frazier Life Sciences portfolio additions include 35Pharma, Vima Therapeutics, AirNexis Therapeutics, Diagonal Therapeutics, Braveheart Bio. These companies were founded in 2020 or later.